News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Raymond M. Shaheen, MD

Articles by Raymond M. Shaheen, MD

Role of Angiogenesis Inhibitors in Cancer Treatment

ByLee M. Ellis, MD, FACS,Wenbiao Liu, MD,Niels Reinmuth, MD,Raymond M. Shaheen, MD,Young Do Jung, MD, PhD,Syed Ahmad, MD

July 1st 2001

Angiogenesis is essential for the growth of both primary andmetastatic tumors. This process, more complex than was previously thought,

Latest Updated Articles

Role of Angiogenesis Inhibitors in Cancer Treatment
July 1st 2001

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

FDA Accepts sNDA for Taletrectinib in ROS1-Positive NSCLC